Pulmatrix, Inc. (PULM)

Pulmatrix Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-14.12	-18.84	-23.37	-19.31	-20.6
Depreciation & Amortization	1.48	1.55	1.24	1.04	0.77
Share-Based Compensation	0.95	1.11	1.16	1.16	2.07
Other Operating Activities	-4.29	-3.18	-1.95	4.62	21
Operating Cash Flow	-15.99	-19.36	-19.73	-12.48	3.23
Capital Expenditures	-0.68	-0.09	-0.14	-0.28	-0.06
Investing Cash Flow	-0.68	-0.09	-0.14	-0.28	-0.06
Share Issuance / Repurchase	0.05	1.38	37.28	20.98	17.55
Other Financing Activities	-	-0.15	6.19	-	0.16
Financing Cash Flow	0.05	1.23	43.48	20.98	17.71
Net Cash Flow	-16.61	-18.21	23.6	8.22	20.88
Free Cash Flow	-16.66	-19.44	-19.87	-12.76	3.17
Free Cash Flow Margin	-228.30%	-320.24%	-384.43%	-101.03%	40.10%
Free Cash Flow Per Share	-4.56	-5.64	-7.34	-8.88	3.79

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).